Oxford Lymphoid Disorders Study Group
The Oxford Lymphoid Disorders Study Group (OLDSG) was launched in September 2020, and brings together a network of researchers and clinicians from across the University of Oxford and Oxford University Hospitals Trust.
At present, around 3-4% of people will develop either lymphoma or Chronic Lymphocytic Leukaemia (CLL) during their lifetime. Together, lymphoma and CLL represent the commonest blood cancer by some margin.
The purpose of OLDSG is to:
- to increase the visibility of lymphoid disorder research in the university
- to foster collaborations between clinicians and laboratory-based scientists leading to high quality translational projects
- to interact with patients and the public at all levels of project development to deliver research which impacts directly on patient need
Group members work on a range of issues relating to lymphoid disorders, haematology, immunology, molecular diagnostics and late effects research.
BLOOD CANCER NEWS
1 September 2021
Researchers from Oxford University and OUH are joining celebrations for the first world CLL day on 1 September 2021.
6 July 2021
Botnar Research Centre researchers have developed standalone long-read sequencing of single cells technology that could open new avenues into the causes of diseases like cancer.